Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPL | P06858 | 5/20 | 0.55 |
| ▸ | LIPG | Q9Y5X9 | 5/20 | 0.55 |
| ▸ | THRB | P10828 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.41 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.40 |
| ▸ | MGLL | Q99685 | 1/20 | 0.40 |
| ▸ | PLK1 | P53350 | 1/20 | 0.40 |
| ▸ | PPARG | P37231 | 1/20 | 0.40 |
| ▸ | PPARA | Q07869 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | CNR1 | P21554 | 1/20 | 0.39 |
| ▸ | CNR2 | P34972 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18205777 | 0.94 | LPL (0.50) | LPLLIPGTHRBALDH1A1CA1 | |
| SCHEMBL2773646 | 0.88 | CA1 (0.58) | LPLLIPGTHRBALDH1A1CA1 | |
| SCHEMBL756017 | 0.86 | LPL (0.59) | LPLLIPGTHRBALDH1A1CA1 | |
| SCHEMBL29172603 | 0.85 | LPL (0.61) | LPLLIPGTHRBALDH1A1CA1 | |
| SCHEMBL28854544 | 0.85 | LPL (0.61) | LPLLIPGTHRBALDH1A1CA1 | |
| SCHEMBL11523976 | 0.85 | LPL (0.61) | LPLLIPGTHRBALDH1A1CA1 | |
| SCHEMBL30805731 | 0.85 | LPL (0.61) | LPLLIPGTHRBALDH1A1CA1 | |
| SCHEMBL2770832 | 0.85 | LPL (0.61) | LPLLIPGTHRBALDH1A1CA1 | |
| SCHEMBL2769522 | 0.85 | LPL (0.61) | LPLLIPGTHRBALDH1A1CA1 | |
| SCHEMBL28099086 | 0.85 | LPL (0.61) | LPLLIPGTHRBALDH1A1CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119707650-A | Functionalized-surface chiral column aromatic hydrocarbon and preparation method and application thereof | 宁夏大学 | 2025-03-28 | — | — | CN | claimed |
| CN-115928264-B | Preparation method of continuous silicon carbide fiber containing metal in near-stoichiometric ratio | 湖南泽睿新材料有限公司 | 2024-02-20 | — | — | CN | claimed |
| JP-10291945-A | — | — | None | — | — | JP | disclosed |
| CN-115928264-B | Preparation method of continuous silicon carbide fiber containing metal in near-stoichiometric ratio | 湖南泽睿新材料有限公司 | 2024-02-20 | — | — | CN | disclosed |
| CN-116462630-A | Quinoline low-temperature curing agent, polyimide and photosensitive resin | 深圳先进电子材料国际创新研究院 | 2023-07-21 | — | — | CN | disclosed |
| CN-114874186-A | Glutaminyl cyclase isoenzyme inhibitor and preparation method and application thereof | 深圳大学 | 2022-08-09 | — | — | CN | disclosed |
| US-8586803-B2 | Chlorofluorobenzene compound, optically isotropic liquid crystal medium and optical device | JNC CORPORATION (JP) | 2013-11-19 | — | — | US | disclosed |
| US-8586153-B2 | Chlorofluorobenzene compound, optically isotropic liquid crystal medium and optical device | JNC CORPORATION (JP) | 2013-11-19 | — | — | US | disclosed |
| US-20130088658-A1 | CHLOROFLUOROBENZENE COMPOUND, OPTICALLY ISOTROPIC LIQUID CRYSTAL MEDIUM AND OPTICAL DEVICE | HASEBA YASUHIRO (JP) | 2013-04-11 | — | — | US | disclosed |
| US-20130085306-A1 | CHLOROFLUOROBENZENE COMPOUND, OPTICALLY ISOTROPIC LIQUID CRYSTAL MEDIUM AND OPTICAL DEVICE | HASEBA YASUHIRO (JP) | 2013-04-04 | — | — | US | disclosed |
| US-8343595-B2 | Chlorofluorobenzene compound, optically isotropic liquid crystal medium, and optical device | JNC CORPORATION (JP) | 2013-01-01 | — | — | US | disclosed |
| EP-1182195-A1 | CYCLIC COMPOUNDS AND USES THEREOF | Takeda Chemical Industries, Ltd. (JP) | 2002-02-27 | — | — | EP | disclosed |
| EP-1140896-A1 | BENZOTHIEPIN-ANILIDE DERIVATIVES, THEIR PRODUCTION AND THEIR USE FOR ANTAGONIZING CCR-5 | Takeda Chemical Industries, Ltd. (JP) | 2001-10-10 | — | — | EP | disclosed |
| US-6235771-B1 | AIDS THERPAY | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2001-05-22 | — | — | US | disclosed |
| WO-2000037455-A1 | BENZOTHIEPIN-ANILIDE DERIVATIVES, THEIR PRODUCTION AND THEIR USE FOR ANTAGONIZING CCR-5 | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2000-06-29 | — | — | WO | disclosed |
| EP-0952135-A1 | Naphthalene derivative and liquid crystal composition comprising the same | DAINIPPON INK AND CHEMICALS, INC. (JP) | 1999-10-27 | — | — | EP | disclosed |
| JP-H10291945-A | LIQUID CRYSTALLINE COMPOUND HAVING NEGATIVE ANISOTROPY VALUE OF DIELECTRIC CONSTANT, LIQUID CRYSTAL COMPOSITION CONTAINING THE SAME AND LIQUID CRYSTAL DISPLAY ELEMENT USING THE COMPOSITION | CHISSO CORP | 1998-11-04 | — | — | JP | disclosed |
| EP-0535635-B1 | Tolane derivative, liquid crystal composition containing the derivative, and liquid crystal display device using the composition | SEIKO EPSON CORP (JP) | 1996-08-21 | — | — | EP | disclosed |
| US-5437815-A | Blending with ordinary liquid crystal compounds broadens practical temperature range of composition and produces an enlarged double refraction anisotropy | SEIKO EPSON CORPORATION (JP) | 1995-08-01 | — | — | US | disclosed |
| EP-0535635-A1 | Tolane derivative, liquid crystal composition containing the derivative, and liquid crystal display device using the composition | SEIKO EPSON CORPORATION (JP) | 1993-04-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130085306-A1 | CHLOROFLUOROBENZENE COMPOUND, OPTICALLY ISOTROPIC LIQUID CRYSTAL MEDIUM AND OPTICAL DEVICE | DDT, BRAF, CFAP410 | LPL 2538/4885LIPG 2319/4885THRB 4072/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.